Vickerman P - Search Results

1

Pilot postal birth cohort HCV Screening in UK primary care.

Simmons R, Powell A, Ijaz S, Mandal S, Shute J, Mohammadi Y, Lattimore M, McOwat K, Moore H, O'Rourke A, Desai M, MacLeod J, Asgharzadeh A, Ward Z, Vickerman P, Harris R, Foster G, Roberts K, Hickman M. Simmons R, et al. Among authors: vickerman p. Br J Gen Pract. 2024 Jul 5:BJGP.2024.0219. doi: 10.3399/BJGP.2024.0219. Online ahead of print. Br J Gen Pract. 2024. PMID: 38969354

2

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users.

Vickerman P, Hickman M, Rhodes T, Watts C. Vickerman P, et al. J Acquir Immune Defic Syndr. 2006 Jul;42(3):355-61. doi: 10.1097/01.qai.0000219788.73539.47. J Acquir Immune Defic Syndr. 2006. PMID: 16645549

3

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

Vickerman P, Hickman M, Judd A. Vickerman P, et al. Int J Epidemiol. 2007 Apr;36(2):396-405. doi: 10.1093/ije/dyl276. Epub 2007 Jan 11. Int J Epidemiol. 2007. PMID: 17218325

4

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.

Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB. Hickman M, et al. Among authors: vickerman p. Addiction. 2007 Apr;102(4):597-606. doi: 10.1111/j.1360-0443.2006.01710.x. Addiction. 2007. PMID: 17362293

5

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.

Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Hope V, et al. Among authors: vickerman p. BMC Infect Dis. 2008 Sep 18;8:120. doi: 10.1186/1471-2334-8-120. BMC Infect Dis. 2008. PMID: 18801177 Free PMC article.

6

If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.

Hickman M, Vickerman P, Macleod J, Lewis G, Zammit S, Kirkbride J, Jones P. Hickman M, et al. Among authors: vickerman p. Addiction. 2009 Nov;104(11):1856-61. doi: 10.1111/j.1360-0443.2009.02736.x. Addiction. 2009. PMID: 19832786

7

Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis.

Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Vickerman P, et al. Addiction. 2010 Feb;105(2):311-8. doi: 10.1111/j.1360-0443.2009.02759.x. Epub 2009 Nov 16. Addiction. 2010. PMID: 19922515 Review.

8

Policy resistance to harm reduction for drug users and potential effect of change.

Rhodes T, Sarang A, Vickerman P, Hickman M. Rhodes T, et al. Among authors: vickerman p. BMJ. 2010 Jul 13;341:c3439. doi: 10.1136/bmj.c3439. BMJ. 2010. PMID: 20627977 Free article. No abstract available.

9

Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere.

Vickerman P, Martin N, Hickman M. Vickerman P, et al. Drug Alcohol Depend. 2011 Jan 15;113(2-3):83-5; discussion 86-7. doi: 10.1016/j.drugalcdep.2010.08.001. Epub 2010 Sep 15. Drug Alcohol Depend. 2011. PMID: 20832198

10

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.

Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Cornish R, et al. Among authors: vickerman p. BMJ. 2010 Oct 26;341:c5475. doi: 10.1136/bmj.c5475. BMJ. 2010. PMID: 20978062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters